Ilan Richter
@ilanrichter
MD MPH | Advanced HF, MCS & HTx fellow, CUIMC | Father of 3 | Believer in data, technology and people
ID: 39769243
13-05-2009 15:14:32
6,6K Tweet
2,2K Takipçi
2,2K Takip Edilen
Rockstar Dor Lotan, MD presenting primary results from the Ramp It Up 3 study at The ISHLT #ISHLT2025 late breaking clinical science session 💪🏻💪🏻💪🏻 Nir Uriel, MD MSc Gabriel Sayer ColumbiaCardiology
🤯 Results from The ISHLT’s relaunching of IMACS, a global MCS registry by Montefiore Health System’s Danny Goldstein, incredible outcomes in Asia/Pacific as compared to US and Europe! #ISHLT2025 JHLT Jennifer Cowger
Learning from the best of the best; Melana Yuzefpolskaya Jennifer Cowger Ezequiel Molina on getting time on your side in treating advanced heart failure. The ISHLT #ISHLT2025
Illuminating introduction by Navin Kapur to the CSWG, where we are and where we’re going session. @manreetkanwar Ulrich Jorde The ISHLT #ISHLT2025 Where, who and how we’re randomizing to trials makes a world of difference.
Electrostatic discharge may lead to complete HeartMate 3 pump stoppage—awareness and education can prevent this serious complication Nir Uriel, MD MSc @ersied727 Dor Lotan, MD Ilan Richter @ELadBoaz #AHAJournals ahajrnls.org/4k5jb8h
Excited to share I'll serve as Faculty at New York Valves: The Structural Heart Summit, taking place June 25–27, 2025 in New York City. Come join me! #NYValves2025 Cardiovascular Research Foundation NewYork-Presbyterian ColumbiaCardiology
What are the clinical implications of +ddcfDNA in HTx pts with negative EMB? We observed a significantly higher risk of adverse clinical events (mortality/graft dysfunction) in this specific cohort Now in Circ: Heart Failure ahajournals.org/doi/10.1161/CI…